Automated Cell Culture Market

Automated cell culture is a process in which the growth and maintenance of cell culture are taken with advanced techniques. Cell culture is a process of removing the cells from the source to grow under the specified technical environment outward of the natural environment. Automated cell culture performs the steps involved in growing and maintaining the cell culture system. Traditionally, cell culture has been a manual process that requires many hours of repetitive, painstaking work to maintain absolute sterility. The automation in the steps involved in cell culture has several advantages, such as reducing time and saving labor costs. Automation ensures consistency of the procedure and provides sterility that even the best technicians cannot attain. Automated cell culture systems are easy to operate and capable of handling large volumes of culture as scale-up is quicker with automated systems.

The global automated cell culture market was valued at USD 8,579.8 million in 2019, and the market is estimated to grow at USD 16,287.9 million by 2027. It is expected to register a CAGR of 8.18% during the forecast period of 2020 to 2027.

The global automated cell culture market has been segmented based on lab type, product, application, and end user.

On the basis of lab type, the modular automation segment accounted for the largest market share of 67.10% in 2019, with a market value of USD 11,022.2 million, which is projected to register a CAGR of 8.34% during the forecast period.

Based on product, the consumables segment accounted for the largest market share of 56.1% in 2019, with a market value of USD 4,814.0 million, which is projected to register a CAGR of 8.61% during the forecast period.

On the basis of application, the biopharmaceutical production segment accounted for the largest market share of 22.1% in 2019, with a market value of USD 1,895.8 million, which is projected to register a CAGR of 8.34% during the forecast period.

Based on end user, the pharmaceutical & biotechnology companies segment accounted for the largest market share of 37.8% in 2019, with a market value of USD 3,242.6 million, which is projected to register a CAGR of 8.89% during the forecast period.

Factors that drive the market growth are fewer errors, lower contamination, and decreased human efforts. An increase in demand for research on regenerative medicines and stem cells is also one of the factors for growth apart for the rising number of patients suffering from neurological disorders.